Metis Global Partners’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.35M | Sell |
115,606
-7,119
| -6% | -$330K | 0.14% | 135 |
|
|
2025
Q1 | $7.48M | Buy |
122,725
+16,222
| +15% | +$989K | 0.21% | 85 |
|
|
2024
Q4 | $6.02M | Buy |
106,503
+5,859
| +6% | +$331K | 0.18% | 91 |
|
|
2024
Q3 | $5.21M | Buy |
100,644
+4,687
| +5% | +$243K | 0.16% | 109 |
|
|
2024
Q2 | $3.99M | Sell |
95,957
-21,043
| -18% | -$874K | 0.14% | 124 |
|
|
2024
Q1 | $6.34M | Sell |
117,000
-2,251
| -2% | -$122K | 0.23% | 69 |
|
|
2023
Q4 | $6.12M | Buy |
119,251
+17,479
| +17% | +$897K | 0.24% | 64 |
|
|
2023
Q3 | $5.91M | Buy |
101,772
+13,122
| +15% | +$762K | 0.29% | 61 |
|
|
2023
Q2 | $5.67M | Sell |
88,650
-496
| -0.6% | -$31.7K | 0.31% | 56 |
|
|
2023
Q1 | $6.18M | Buy |
89,146
+22,128
| +33% | +$1.53M | 0.4% | 48 |
|
|
2022
Q4 | $4.82M | Buy |
67,018
+28,364
| +73% | +$2.04M | 0.43% | 45 |
|
|
2022
Q3 | $2.75M | Buy |
38,654
+1,846
| +5% | +$131K | 0.44% | 42 |
|
|
2022
Q2 | $2.83M | Buy |
36,808
+1,839
| +5% | +$142K | 0.45% | 42 |
|
|
2022
Q1 | $2.55M | Buy |
34,969
+15,607
| +81% | +$1.14M | 0.31% | 62 |
|
|
2021
Q4 | $1.21M | Buy |
+19,362
| New | +$1.21M | 0.34% | 65 |
|